Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials
This review looked at published clinical trials of psilocybin for depression. It found 11 trials (six open‑label and five double‑blind randomized trials) that report rapid antidepressant and anti‑anxiety effects in some patients. The paper describes how psilocybin acts on serotonin 5‑HT2A receptors, may boost brain plasticity, and may lower brain…